Non-opioid Pain Patches Market - Global Industry Analysis, Size, Trends, Growth, Trends, and Forecast 2018 - 2028
Global Non-Opioid Pain Patches Market: Overview
Need to move away from opioid based patches in order to fight the growing menace of its addiction is leading way for growth in the global non-opioid pain patches market. The situation in 2017 got so bad in terms of opioid addiction that the United States declared it a national emergency. And, the problem is not unique to US. Several countries have the issue marked as high priority and are looking for alternatives to opioid patches. Besides, the market is driven by an increase in chronic and acute pain related issues.
Thus, the global non-opioid patches market will see a steady CAGR (Compound Annual Growth Rate). It will create growth opportunities for market players to tap into and also contribute to the market worth of the opioid patches.
Global Non-Opioid Pain Patches market: Competitive Landscape
The landscape of Global Non-Opioid Pain Patches market is witnessing significant developments that are shaping both its competitive future as well as overall appearance. A glimpse is provided below.
The global non-opioid pain patches market is highly fragmented. And, prominent players in the global non-opioid pain patches market are Acorda Therapeutics; Teva Pharmaceutical Industries Ltd.; GlaxoSmithKline plc; Endo Pharmaceuticals, Inc.; Hisamitsu Pharmaceutical Co., Inc.; IBSA Institut Biochimque SA; Alkermes; Teikoku Seiyaku Co. Ltd.; Capsugel; and Mylan N.V. It is not hard to guess that the competition is intense too.
Current focus for most companies to chart growth in the global non-opioid pain patches market is through improving product and market them better. In order to capture opportunities, it is important to focus on use of better technology. Besides, in order to stay ahead of the curves, players often take to mergers and acquisitions. They also opt for strategic partnerships and collaborations to explore synergies for future growth.
Global Non-Opioid Pain Patches Market: Key trends and driver
The global Non-opioid pain patches market is being driven on to a high growth trajectory, owing to a number of factors. Some of the most potent ones are outlined below:
Global Non-Opioid Pain Patches Market: Regional Analysis
North America and Europe will hold the lion’s share owing to presence of prominent market players and rapidly rising geriatric population. But the region that will present players with new growth opportunities is the Asia Pacific (APAC). With people seeing rising disposable incomes and countries already struggling with drug abuse, there will be a massive increase in demand for the non-opioid pain patches. It is a result of both a great performance economically of these nations as well as rising problem of drug use.
The report is segmented into the following:
Patch Type (Revenue, USD Million, 2015 - 2026)
Distribution Channel Outlook (Revenue, USD Million, 2015 - 2026)
The study presents reliable qualitative and quantitative insights into:
The regional analysis covers:
The vast market research data included in the study is the result of extensive primary and secondary research activities. Surveys, personal interviews, and inputs from industry experts form the crux of primary research activities and data collected from trade journals, industry databases, and reputable paid sources form the basis of secondary research. The report also includes a detailed qualitative and quantitative analysis of the market, with the help of information collected from market participants operating across key sectors of the market value chain. A separate analysis of macro- and micro-economic aspects, regulations, and trends influencing the overall development of the market is also included in the report.
Highlights of the report:
Note: Immense care has been taken to present data with the highest levels of accuracy in all TMRResearch reports. Nevertheless, recent developments related to market/vendor landscape may take time to reflect in the analysis.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report